Is Amarin AMRN Stock a Good Buy for Investors in 2021?

Currently, Vascepa is Amarin’s only product. The drug obtained FDA approval as a heart treatment for patients with elevated triglyceride levels. Also, Vascepa is being used in clinical trials by third parties to assess if it has an impact on COVID-19, colon cancer, Alzheimer’s, non-alcoholic steatohepatitis, and other diseases.

View more information: https://marketrealist.com/p/amrn-good-stock-to-buy/

See more articles in category: Finance
See also  The Early History of Harley-Davidson: The Motorcycle Pioneer

Leave a Reply

Back to top button